{"created":"2023-07-27T06:29:26.647313+00:00","id":14232,"links":{},"metadata":{"_buckets":{"deposit":"d6bbfdd9-8234-488d-92c6-7139df67531b"},"_deposit":{"created_by":3,"id":"14232","owners":[3],"pid":{"revision_id":0,"type":"depid","value":"14232"},"status":"published"},"_oai":{"id":"oai:kanazawa-u.repo.nii.ac.jp:00014232","sets":["1132:1133:1134"]},"author_link":["320","24474"],"item_4_biblio_info_8":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2015-01-01","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"1","bibliographicPageEnd":"131","bibliographicPageStart":"127","bibliographicVolumeNumber":"1","bibliographic_titles":[{"bibliographic_title":"Annals of Nuclear Cardiology"}]}]},"item_4_description_21":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"Since the advent of 123I-meta-iodobenzylguanidine（MIBG）in 1990s, it has been widely used in clinical practice in Japan. Based on the wide range of clinical applications, 123I MIBG is now incorporated in Japanese Circulation Society)s guidelines of nuclear cardiology. The major role of 123I MIBG has been in determination of severity and prognostic evaluation of heart failure. In addition, assessment of the treatment by various types of medications has been the second major role of 123 I MIBG imaging. Compared with the conventional clinical parameters of heart failure, additive values of 123I MIBG depend on how it reflects the patient condition more accurately, and how it relates to improvement in the patient outcome. 123 I MIBG is also now available for cardiac imaging in the USA and Europe. Unified methodology and further studies focusing on clinical decision-making are the next required steps to document MIBG utility.","subitem_description_type":"Abstract"}]},"item_4_publisher_17":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"The Japanese Society of Nuclear Cardiology =日本心臓核医学会"}]},"item_4_relation_12":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_relation_type":"isVersionOf","subitem_relation_type_id":{"subitem_relation_type_id_text":"10.17996/ANC. 01.01.127","subitem_relation_type_select":"DOI"}}]},"item_4_relation_28":{"attribute_name":"関連URI","attribute_value_mlt":[{"subitem_relation_type_id":{"subitem_relation_type_id_text":"http://www.jsnc.org/annals-nuclear-cardiology","subitem_relation_type_select":"URI"}},{"subitem_relation_type_id":{"subitem_relation_type_id_text":"http://www.jsnc.org/files/paper/anc/01-01/21_ANC1-01.pdf","subitem_relation_type_select":"URI"}}]},"item_4_rights_23":{"attribute_name":"権利","attribute_value_mlt":[{"subitem_rights":"© The Japanese Society of Nuclear Cardiology"}]},"item_4_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"2189-3926","subitem_source_identifier_type":"ISSN"}]},"item_4_version_type_25":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_ab4af688f83e57aa","subitem_version_type":"AM"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Nakajima, Kenichi"}],"nameIdentifiers":[{},{},{},{}]},{"creatorNames":[{"creatorName":"Jacobson, Arnold F."}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2017-10-03"}],"displaytype":"detail","filename":"ME-PR-NAKAJIMA-K-127.pdf","filesize":[{"value":"778.2 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"ME-PR-NAKAJIMA-K-127.pdf","url":"https://kanazawa-u.repo.nii.ac.jp/record/14232/files/ME-PR-NAKAJIMA-K-127.pdf"},"version_id":"fa54bc25-3493-4985-bf9e-5e6227d883f1"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"123I MIBG: Are There Any Additional Roles in Clinical Practice of Heart Failure?","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"123I MIBG: Are There Any Additional Roles in Clinical Practice of Heart Failure?"}]},"item_type_id":"4","owner":"3","path":["1134"],"pubdate":{"attribute_name":"公開日","attribute_value":"2017-10-03"},"publish_date":"2017-10-03","publish_status":"0","recid":"14232","relation_version_is_last":true,"title":["123I MIBG: Are There Any Additional Roles in Clinical Practice of Heart Failure?"],"weko_creator_id":"3","weko_shared_id":3},"updated":"2023-07-27T16:58:12.912443+00:00"}